Month: October 2018

KEY CLINICAL OUTCOMES

Articles

Streamlined solutions provided by Cognitive Clinical Trials (CCT) related to the treatment and prevention of Alzheimer’s disease...

Read More

REGULATORY

Articles

SNAPSHOTS: Copiktra receives FDA approval for CLL and FL, Relief for tazemetostat developers after FDA lifted partial clinical hold,...

Read More

The novel therapy for brain cancer treatments

Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant, Snippets

Laser Interstitial Thermal Therapy (LITT) is one of a hopeful treatment for brain cancer. Now, researchers are also using lasers to...

Read More

Notizia

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, DelveInsight's Oncology based Reports, Gene Therapy Products, Notizia, Pharma Consultant

FDA approves transthyretin amyloidosis therapy of Akcea, Ionis Patients with an orphan, hereditary disease that is transthyretin...

Read More

The Business Cocktails

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant, The Business Cocktail

Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 Million Hologic, a global champion of women’s...

Read More

Antidepressants withdrawal hits millions of people

Business Consultant, Pharma Consultant, Snippets • 4 Comments

Millions of people get bad side-effects when trying to withdraw antidepressants. The All Party Parliamentary Group for Prescribed Drug...

Read More
Close